+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Colorectal Cancer Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 362135
  • Report
  • 351 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Amgen
  • Bayer Ag
  • F. Hoffmann-La Roche Ag
  • Merck Kgaa
  • Novartis International Ag
  • Spectrum Pharmaceuticals
  • MORE
The Colorectal Cancer Therapeutics market worldwide is projected to grow by US$1.4 Billion, driven by a compounded growth of 2.1%. Chemotherapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 2.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.5 Billion by the year 2025, Chemotherapy will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$53.8 Million to the region's size and clout in the next 5 to 6 years. Over US$40.9 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Chemotherapy will reach a market size of US$113.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.3% over the next couple of years and add approximately US$370.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Amgen, Inc.
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Novartis International AG
  • Spectrum Pharmaceuticals
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen
  • Bayer Ag
  • F. Hoffmann-La Roche Ag
  • Merck Kgaa
  • Novartis International Ag
  • Spectrum Pharmaceuticals
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Colorectal Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Colorectal Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025

CANADA

JAPAN

CHINA

EUROPE

Market Facts & Figures

European Colorectal Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION

AMGEN

BAYER AG

F. HOFFMANN-LA ROCHE AG

MERCK KGAA

NOVARTIS INTERNATIONAL AG

SPECTRUM PHARMACEUTICALS

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen
  • Bayer Ag
  • F. Hoffmann-La Roche Ag
  • Merck Kgaa
  • Novartis International Ag
  • Spectrum Pharmaceuticals
Note: Product cover images may vary from those shown
Adroll
adroll